Emergence of Ciprofloxacin Resistance in Escherichia coli Isolates after Widespread Use of Fluoroquinolones

The evolution (from 1990 to 1996) of fluoroquinolone consumption and resistance and the current patterns of fluoroquinolone usage were examined in a 250-bed community hospital in Spain. Fluoroquinolone consumption increased from 1392 g in 1990 to 3203 g in 1996 ( p < 0.05). A significant increase...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic microbiology and infectious disease 1998-02, Vol.30 (2), p.103-107
Main Authors: Ena, Javier, del Mar López-Perezagua, Marı́a, Martı́nez-Peinado, Carmen, de los Angeles Cia-Barrio, Marı́a, Ruı́z-López, Isabel
Format: Article
Language:English
Subjects:
Aged
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Ciprofloxacin - therapeutic use
Contraindications
Drug Resistance, Microbial
Drug Utilization
Escherichia coli - isolation & purification
Humans
Linear Models
Medical sciences
Norfloxacin - therapeutic use
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The evolution (from 1990 to 1996) of fluoroquinolone consumption and resistance and the current patterns of fluoroquinolone usage were examined in a 250-bed community hospital in Spain. Fluoroquinolone consumption increased from 1392 g in 1990 to 3203 g in 1996 ( p < 0.05). A significant increase in ciprofloxacin resistance was observed in Escherichia coli isolated from urine samples (from 3 to 20%, p < 0.00001), but not in those E. coli isolated from blood or other sample cultures. In 69 randomly selected clinical charts, fluoroquinolone was used as prophylaxis, empirical therapy, and specific directed therapy in 20%, 65%, and 15%, respectively. Evaluation of quinolone indication was: first choice agents (29%), alternative agents (49%), experimental agents (4.3%) and, agents with no role (1.4%). Our study shows that the increase in the use of fluoroquinolones is associated with the emergence of ciprofloxacin-resistant E. coli from urinary tract sources. Based on their indications, current quinolone usage can be greatly reduced.
ISSN:0732-8893
1879-0070
DOI:10.1016/S0732-8893(97)00216-2